Abpro Holdings, Inc. SEC filings ABPWW
Abpro Holdings, Inc. has 253 filings in SEC EDGAR's recent list, going back to Dec 2, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 1, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2026 | Aug 19, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 4, 2026 | May 28, 2026 |
| 8-K |
Current report
Listing notice
|
Feb 20, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Feb 11, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Jan 23, 2026 | Jan 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 9, 2025 | Dec 9, 2025 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 22, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 17, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2025 | Oct 10, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2025 | Jul 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2025 | Apr 27, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 24, 2025 | Apr 20, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 16, 2025 | Apr 10, 2025 |
| 8-K |
Current report
Restatement
|
Apr 15, 2025 | Apr 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 8, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 8, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Mar 6, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 21, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 10, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 29, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Nov 26, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 6, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 4, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
Oct 21, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 20, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 4, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 28, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Other events
|
Aug 19, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 6, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Other events
|
Jul 19, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Other events
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 7, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Material agreement
|
May 31, 2024 | May 30, 2024 |
| 8-K |
Current report
Other events
|
May 17, 2024 | May 16, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
Apr 23, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 16, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2024 | Apr 2, 2024 |
| 8-K |
Current report
Other events
|
Mar 19, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 19, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Dec 18, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Other events
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 12, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Oct 18, 2023 | Oct 14, 2023 |
| 8-K |
Current report
Other events
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Apr 18, 2023 | Apr 18, 2023 |
| 8-K |
Current report
Other events
|
Apr 12, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 5, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Other events
|
Mar 4, 2022 | Mar 4, 2022 |
| 8-K |
Current report
Other events
|
Jan 25, 2022 | Jan 19, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jan 19, 2022 | Jan 13, 2022 |
Showing 70 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ABPO (OTC), ABPWW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1893219
- Former names
- Atlantic Coastal Acquisition Corp. II (until Nov 12, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.